Rein Therapeutics, Inc. Earnings Per Share (Basic)
Rein Therapeutics, Inc. (RNTX) reported Earnings Per Share (Basic) of -$0.10 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Rein Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.10.
- Rein Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.19.
- Rein Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.21.
- Rein Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.28.
- Rein Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$1.96.
- Rein Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$3.51.
- Rein Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$3.42.
- Rein Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$6.02.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.10 10-Q · filed 2026-08-14 | -$0.25 10-Q · filed 2026-08-14 | |||||
| 2026-03-31 | -$0.19 10-Q · filed 2026-05-15 | ||||||
| 2025-12-31 | -$1.96 10-K · filed 2026-03-26 | ||||||
| 2025-09-30 | -$0.21 10-Q · filed 2025-11-14 | -$0.74 10-Q · filed 2025-11-14 | |||||
| 2025-06-30 | -$0.28 10-Q · filed 2026-08-14 | -$0.53 10-Q · filed 2026-08-14 | |||||
| 2025-03-31 | -$0.25 10-Q · filed 2026-05-15 | ||||||
| 2024-12-31 | -$3.51 10-K · filed 2026-03-26 | ||||||
| 2024-09-30 | -$0.27 10-Q · filed 2025-11-14 | -$1.31 10-Q · filed 2025-11-14 | |||||
| 2024-06-30 | -$0.45 10-Q · filed 2025-08-14 | -$1.13 10-Q · filed 2025-08-14 | |||||
| 2024-03-31 | -$0.86 10-Q · filed 2025-05-15 | ||||||
| 2023-12-31 | -$3.42 10-K · filed 2025-04-07 | ||||||
| 2023-09-30 | -$0.40 10-Q · filed 2024-11-14 | -$1.85 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | -$0.39 10-Q · filed 2024-08-14 | -$1.45 10-Q · filed 2024-08-14 | |||||
| 2023-03-31 | -$1.05 10-Q · filed 2024-05-15 | ||||||
| 2022-12-31 | -$6.02 10-K · filed 2024-04-15 | ||||||
| 2022-09-30 | -$1.40 10-Q · filed 2023-10-13 | -$0.07 10-Q · filed 2022-11-01 | -$5.02 10-Q · filed 2023-10-13 | -$0.25 10-Q · filed 2022-11-01 | |||
| 2022-06-30 | -$1.76 10-Q · filed 2023-08-11 | -$0.09 10-Q · filed 2022-08-15 | -$3.62 10-Q · filed 2023-08-11 | -$0.18 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | -$1.86 10-Q · filed 2023-05-08 | ||||||
| 2021-12-31 | -$5.89 10-K · filed 2023-03-20 | ||||||
| 2021-09-30 | -$0.07 10-Q · filed 2022-11-01 | -$0.22 10-Q · filed 2022-11-01 | |||||
| 2021-06-30 | -$0.06 10-Q · filed 2022-08-15 | -$0.15 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |